BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7875849)

  • 1. Fatal fulminant hepatic failure due to sodium valproate in an adolescent.
    Puri AS; Sharma BC; Khan EM; Saraswat VA
    Indian Pediatr; 1994 Feb; 31(2):207-10. PubMed ID: 7875849
    [No Abstract]   [Full Text] [Related]  

  • 2. A suspected case of late-onset sodium-valproate-induced hepatic failure.
    van Egmond H; Degomme P; de Simpel H; Dierick AM; Roels H
    Neuropediatrics; 1987 May; 18(2):96-8. PubMed ID: 3110642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemorrhagic shock and fulminant hepatic failure associated with valproate].
    Fernandez-Fernandez FJ; Garcia-Rego J; Garcia-Jimenez A; Sesma P
    An Med Interna; 1995 Dec; 12(12):606-8. PubMed ID: 8679806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Irreversible valproate-associated liver failure].
    Siemes H; Nau H; Seidel U; Gramm HJ
    Monatsschr Kinderheilkd; 1992 Dec; 140(12):869-75. PubMed ID: 1491708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Encephalopathy associated with hyperammonemia in an alcoholic patient treated with sodium valproate].
    Mattei A; Bernard G; Plauchu G; Paliard P
    Gastroenterol Clin Biol; 1993; 17(6-7):516-7. PubMed ID: 8243949
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fatal hepatic necrosis during treatment with sodium valproate].
    Miguil M; Chlihi A; Mjahed K; Sarf I; Moutawakkil S; Benaguida M
    Cah Anesthesiol; 1995; 43(3):325-6. PubMed ID: 7583902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fulminant hepatic failure caused by ecarazine hydrochloride (a hydralazine derivative).
    Tameda Y; Hamada M; Takase K; Nakano T; Kosaka Y
    Hepatology; 1996 Mar; 23(3):465-70. PubMed ID: 8617425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fatal hepatic failure in a normally developed 5-year-old boy caused by VPA monotherapy].
    König S; Scheffner D; Rauterberg-Ruland I; Kochen W; Hofmann WJ; Wokittel E; Schick U
    Monatsschr Kinderheilkd; 1987 Jun; 135(6):310-3. PubMed ID: 3112563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sodium valproate, hyperammonemia and hepatic encephalopathy].
    Imler M; Warter JM; Marescaux C
    Gastroenterol Clin Biol; 1982 Dec; 6(12):1042. PubMed ID: 6819177
    [No Abstract]   [Full Text] [Related]  

  • 10. Fatal hepatocerebral syndrome in siblings discordant for exposure to valproate.
    Lenn NJ; Ellis WG; Washburn ER; Ruebner B
    Epilepsia; 1990; 31(5):578-83. PubMed ID: 2119302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute fatal liver insufficiency due to valproic acid therapy].
    Binek J; Hany A; Egloff B; Heer M
    Schweiz Med Wochenschr; 1991 Feb; 121(7):228-33. PubMed ID: 2008603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal hepatic failure and sodium valproate.
    Le Bihan G; Bourreille J; Sampson M; Leroy J; Szekely AM; Coquerel A
    Lancet; 1980 Dec; 2(8207):1298-9. PubMed ID: 6108469
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of corticosteroid and exchange-transfusion treatment of acute yellow-phosphorus intoxication.
    Marin GA; Montoya CA; Sierra JL; Senior JR
    N Engl J Med; 1971 Jan; 284(3):125-8. PubMed ID: 5538680
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatic encephalopathy precipitated by sodium valproate therapy.
    Subhash HS; Heddle RJ; Schultz DW; Ring J; Thompson CH
    Med J Aust; 2008 May; 188(9):549. PubMed ID: 18459937
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fulminant liver failure with a fatal outcome due to flutamide].
    Fernández Peña CM; Morano Amado LE; Montes Santiago J; Fachal C
    Med Clin (Barc); 1997 Feb; 108(6):237-8. PubMed ID: 9102495
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is the "specific" treatment of acute hepatic encephalopathy during liver cirrhosis justified?].
    Doffoël M; Vetter D
    Gastroenterol Clin Biol; 1994; 18(12):1055-6. PubMed ID: 7750676
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatic failure associated with imipramine therapy.
    Shaefer MS; Edmunds AL; Markin RS; Wood RP; Pillen TJ; Shaw BW
    Pharmacotherapy; 1990; 10(1):66-9. PubMed ID: 2315196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate-induced hepatic failure in a case of cytochrome c oxidase deficiency.
    Chabrol B; Mancini J; Chretien D; Rustin P; Munnich A; Pinsard N
    Eur J Pediatr; 1994 Feb; 153(2):133-5. PubMed ID: 8157021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe hyperammonaemic encephalopathy resulting from the overlap between hepatic and valproate encephalopathy.
    Izadi Firouzabadi L; Geer K; Mead P;
    Postgrad Med J; 2018 Nov; 94(1117):664. PubMed ID: 30397004
    [No Abstract]   [Full Text] [Related]  

  • 20. Sodium valproate and acute hepatic failure.
    Addison GM; Gordon NS
    Dev Med Child Neurol; 1980 Apr; 22(2):248-9. PubMed ID: 6769734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.